As in hypoxia, tumour cells and immunosuppressor cells, such as MDSCs and tumour endothelial cells, express immune checkpoint molecules like PD‐L and PD‐L2,18, 19 which can neutralize NK cells and induce CTL tolerization.20 This evidence concerns the gene PDCD1LG2 and neoplasm.